Does Mielle Rosemary Oil cause hair loss? This is a question many UK consumers have asked after reports of increased shedding circulated on social media. Mielle Organics Rosemary Mint Scalp & Hair Strengthening Oil contains rosemary essential oil, peppermint oil, and biotin, and is marketed to support scalp health and reduce breakage. However, it is a cosmetic product — not a licensed medical treatment — and understanding the difference between product-related reactions and underlying hair loss conditions is essential before drawing conclusions. This article examines the evidence, potential side effects, and when to seek professional advice.

What Is Mielle Rosemary Oil and How Is It Used?

Mielle Rosemary Oil is a cosmetic scalp oil containing rosemary, peppermint, and biotin, applied topically by massaging into the scalp. It is regulated as a cosmetic under UK law, not as a licensed medicine.

Mielle Organics Rosemary Mint Scalp & Hair Strengthening Oil is a commercially available hair care product that gained significant popularity, particularly on social media platforms such as TikTok, where users shared anecdotal reports of improved hair growth and scalp health. The product contains rosemary oil as a key ingredient, alongside peppermint oil, biotin, and a blend of carrier oils including coconut and jojoba oil.

Rosemary oil is derived from the plant Rosmarinus officinalis and has been used in traditional medicine for centuries. In modern hair care, it is typically applied topically to the scalp, either as a diluted essential oil or as part of a formulated product. Users commonly apply it by massaging a small amount directly into the scalp, sometimes leaving it on before washing, or incorporating it into their regular hair care routine.

The product is marketed towards individuals seeking to strengthen hair, reduce breakage, and support scalp health. It is widely available in the UK through online retailers and beauty supply stores. Undiluted essential oils should not be applied directly to the scalp, as this increases the risk of irritation; always use a formulated product or ensure appropriate dilution, and perform a patch test for at least 48–72 hours before full application.

It is important to note that Mielle Rosemary Oil is a cosmetic product, not a licensed medicinal treatment. In the UK, cosmetics are regulated under the UK Cosmetics Regulation, enforced by the Office for Product Safety and Standards (OPSS). Cosmetic products cannot legally claim to treat or prevent medical conditions, and they do not carry the same regulatory oversight as medicines approved by the MHRA. If you suspect an adverse reaction to a cosmetic product, this can be reported via the MHRA Yellow Card website (yellowcard.mhra.gov.uk), where cosmetic product concerns are directed to OPSS.

Experiencing these side effects? Our pharmacists can help you navigate them →

Can Rosemary Oil Cause or Worsen Hair Loss?

There is no established clinical evidence that rosemary oil directly causes hair loss when used as directed. Reported shedding is more likely explained by scalp massage, contact dermatitis, or pre-existing hair loss conditions.

There is no established clinical evidence to suggest that rosemary oil, when used as directed, directly causes hair loss in the general population. However, a number of users have reported increased shedding after beginning use of Mielle Rosemary Oil, which has understandably raised concern. It is important to understand the likely explanations for this experience before drawing conclusions.

One consideration is the phenomenon known as telogen effluvium — a temporary form of diffuse hair shedding. Telogen effluvium is most commonly triggered by systemic stressors such as illness, significant nutritional deficiency, hormonal change, or psychological stress, and typically becomes noticeable approximately two to three months after the triggering event. Topical products are unlikely to trigger telogen effluvium directly unless they cause significant scalp inflammation, such as allergic contact dermatitis. Scalp massage, which often accompanies oil application, can also dislodge hairs already in the telogen (resting) phase and due to shed naturally, creating the impression of increased hair loss even when the product itself is not the underlying cause.

Some individuals may experience a contact dermatitis or allergic reaction to one or more ingredients in the formulation — including essential oils such as rosemary or peppermint — which could contribute to localised scalp inflammation and subsequent hair shedding. Those with sensitive skin or a history of allergic reactions to botanical or fragrance ingredients should exercise particular caution. If you notice marked scalp inflammation, pain, or patchy hair loss after using any product, you should stop using it and seek medical advice promptly.

Not sure if this is normal? Chat with one of our pharmacists →

It is also worth considering that many people begin using hair growth products at a time when they are already experiencing hair loss, making it difficult to distinguish between pre-existing shedding and any product-related effect. In summary, while there is no established direct causal link between Mielle Rosemary Oil and hair loss, individual reactions can vary, and any persistent or worsening shedding warrants further investigation by a GP or dermatologist.

Sources: NHS: Hair loss (alopecia); British Association of Dermatologists (BAD) patient leaflet: Telogen effluvium; NICE Clinical Knowledge Summary (CKS): Female pattern hair loss; Male pattern hair loss.

Reported Side Effects and Scalp Reactions to Be Aware Of

Common adverse reactions include scalp irritation, redness, contact dermatitis, and increased shedding. Essential oils are recognised sensitisers, so a patch test of at least 48–72 hours is recommended before use.

As with any topical product containing essential oils, Mielle Rosemary Oil carries a risk of adverse reactions in some users. The most commonly reported side effects include:

• Scalp irritation or burning sensation, particularly in individuals with sensitive skin

• Redness and inflammation at the site of application

• Contact dermatitis, which may present as itching, flaking, or a rash on the scalp or surrounding skin

• Increased hair shedding, which may be temporary and related to scalp massage or product-induced inflammation

• Allergic reactions to rosemary, peppermint, or other botanical or fragrance components

• Folliculitis or worsening of seborrhoeic dermatitis, as occlusive oils may exacerbate these conditions in susceptible individuals

Essential oils are highly concentrated plant extracts and are recognised sensitisers — meaning repeated exposure can increase the likelihood of developing an allergic response over time, even in individuals who initially tolerated the product well. Peppermint oil contains menthol, which can cause a cooling or tingling sensation that some users may find uncomfortable or irritating.

To reduce the risk of adverse reactions, perform a patch test before full application — apply a small amount to the inner forearm or behind the ear and wait at least 48–72 hours to observe any reaction. If irritation, redness, or swelling occurs, discontinue use immediately.

Individuals with pre-existing scalp conditions such as psoriasis, seborrhoeic dermatitis, or eczema should seek advice from a GP or dermatologist before introducing new topical products, as essential oils may exacerbate these conditions. Avoid contact with the eyes; if the product enters the eyes, rinse thoroughly with water. If you experience swelling of the face, lips, or throat, or difficulty breathing, seek urgent medical attention.

Due to limited safety data on essential oils during pregnancy and breastfeeding, those who are pregnant or breastfeeding should seek advice from a healthcare professional before use.

Reporting adverse reactions: Suspected adverse reactions to cosmetic products can be reported via the MHRA Yellow Card website (yellowcard.mhra.gov.uk), where cosmetic concerns are directed to OPSS. Suspected adverse reactions to medicines or medical devices should be reported to the MHRA directly via the same Yellow Card scheme.

Sources: NHS: Contact dermatitis; BAD: Fragrance allergy and contact dermatitis; MHRA Yellow Card scheme.

What the Evidence Says About Rosemary Oil and Hair Growth

A 2015 RCT found rosemary oil comparable to 2% minoxidil for androgenetic alopecia, but the evidence base is limited and rosemary oil is not NICE-recommended or MHRA-licensed for hair loss.

The scientific evidence surrounding rosemary oil and hair growth, whilst generating interest, remains limited and should be interpreted with caution.

The most frequently cited study is a 2015 randomised controlled trial (RCT) published in the journal SKINmed (Panahi et al., 2015), which compared pure rosemary essential oil to 2% minoxidil solution in participants with androgenetic alopecia over six months. The study found that both treatments produced comparable increases in hair count, with rosemary oil associated with less scalp itching. However, this trial had a relatively small sample size, used pure rosemary essential oil rather than a commercially formulated product such as Mielle Rosemary Oil, and compared rosemary oil to 2% minoxidil — a lower-strength preparation than the 5% formulations now more commonly used in the UK. Independent replication in larger, well-designed trials is lacking, and the results cannot be directly extrapolated to commercial blends containing multiple additional ingredients.

Regarding proposed mechanisms, some laboratory and animal studies have examined rosemary leaf extracts — which contain compounds such as carnosic acid and carnosol — for potential effects on hair follicle activity and scalp circulation. It is important to note that rosemary essential oil (produced by steam distillation) has a different chemical composition from rosemary leaf extracts used in many laboratory studies, and the clinical relevance of these preclinical findings to topical essential oil applied to the human scalp remains unproven. Any mechanistic claims should therefore be regarded as hypothetical at this stage.

At present, rosemary oil is not a NICE-recommended or MHRA-licensed treatment for any form of hair loss. Individuals seeking evidence-based treatment for hair loss should discuss options with their GP or a consultant dermatologist.

Sources: Panahi Y et al. SKINmed 2015; NICE CKS: Male pattern hair loss; Female pattern hair loss; BNF: Minoxidil (topical); MHRA/eMC SmPC: Regaine for Men Extra Strength 5% Foam; Regaine for Women Once a Day 5% Foam.

When to Seek Advice from a GP or Dermatologist

Seek medical advice for persistent, patchy, or rapidly progressive hair loss, scalp pain, systemic symptoms, or any severe skin reaction. A GP can arrange blood tests to identify underlying medical causes.

Whilst mild, temporary shedding following the introduction of a new hair product is not uncommon, there are certain signs and symptoms that should prompt a consultation with a GP or dermatologist. It is important not to attribute all hair loss to a topical product, as hair loss can be a symptom of underlying medical conditions that require investigation and treatment.

Seek medical advice if you experience:

• Hair loss that is persistent, progressive, or worsening over several weeks or months

• Patchy hair loss, which may suggest alopecia areata — an autoimmune condition

• Signs that may indicate scarring alopecia, such as scalp pain or tenderness, pustules, scaling, loss of visible follicular openings, or rapid progression — these warrant prompt dermatology referral

• Hair loss accompanied by significant scalp itching, redness, or scaling

• Systemic symptoms such as fatigue, unexplained weight changes, or changes in mood, which may indicate thyroid dysfunction, iron deficiency, or other underlying conditions

• Hair loss following a significant physical or emotional stressor, illness, or change in medication

• Any allergic reaction or severe skin irritation following product use

A GP can arrange relevant investigations — such as full blood count, ferritin, thyroid function tests, and other tests as clinically indicated based on your history and examination — to identify or exclude common medical causes of hair loss. Routine testing for all possible causes is not standard practice; your GP will guide which tests are appropriate for your situation.

If a dermatological cause is suspected, referral to a consultant dermatologist via NHS pathways is the appropriate route; waiting times vary by area. If you choose to seek a private assessment, ensure the clinician is a registered medical specialist. Non-medically qualified practitioners who use the title 'trichologist' are not regulated healthcare professionals in the UK, and their assessments do not replace medical diagnosis or NHS care.

Sources: NHS: Hair loss (alopecia); NICE CKS: Male pattern hair loss; Female pattern hair loss; Alopecia areata; BAD patient leaflets: Scarring alopecia (lichen planopilaris/frontal fibrosing alopecia); Alopecia areata.

Safer Ways to Support Hair Health and Manage Hair Loss

Licensed options including topical minoxidil and finasteride (for men) have the strongest evidence base for androgenetic alopecia. Addressing nutritional deficiencies and adopting gentle hair care practices also supports hair health.

For those concerned about hair loss or seeking to support overall hair health, there are several evidence-informed approaches that can be considered alongside — or instead of — topical oils. A holistic approach that addresses both internal and external factors is generally most effective.

Nutritional support plays an important role in hair health. Deficiencies in iron, ferritin, vitamin D, zinc, and B vitamins have been associated with hair shedding. A balanced diet rich in lean proteins, leafy green vegetables, nuts, seeds, and oily fish provides many of the micronutrients essential for healthy hair follicle function. Supplementation should only be considered where a deficiency has been confirmed through blood testing, as excessive intake of certain nutrients can be harmful. In particular, high-dose biotin supplements can interfere with a number of immunoassay-based blood tests — including thyroid function tests and troponin — and should be avoided unless a deficiency has been confirmed; inform your GP or any healthcare professional if you are taking biotin supplements before blood tests are arranged.

Licensed treatments for hair loss include:

• Topical minoxidil (available over the counter in the UK as a 2% or 5% solution or 5% foam) — licensed for androgenetic alopecia in both men and women. The 5% foam formulations are licensed for use in men (Regaine for Men Extra Strength) and women (Regaine for Women Once a Day) in the UK. Consult the product's patient information leaflet or speak to a pharmacist or GP for guidance on appropriate use.

• Oral minoxidil tablets are licensed in the UK for severe hypertension (brand name Loniten), not for hair loss. Their use for hair loss is therefore off-label, should only be initiated by a specialist with appropriate cardiovascular monitoring, and is not a routine first-line option.

• Finasteride (prescription only, for men with androgenetic alopecia) — a 5-alpha reductase inhibitor with a well-established evidence base. It is a prescription-only medicine (POM) for men and is contraindicated in women who are pregnant or may become pregnant due to the risk of harm to a male foetus. The MHRA has issued important safety guidance on finasteride, highlighting risks of sexual dysfunction (which may persist after stopping treatment) and psychiatric side effects including depression. Patients prescribed finasteride should receive a patient alert card and discuss these risks with their prescribing clinician. Further information is available via the MHRA Drug Safety Update and the medicine's patient information leaflet.

• Corticosteroid treatments for inflammatory or autoimmune hair loss conditions (such as alopecia areata), prescribed and supervised by a dermatologist.

Gentle hair care practices can also help minimise breakage and shedding. These include avoiding excessive heat styling, using a wide-toothed comb on wet hair, reducing the frequency of chemical treatments, and choosing mild, sulphate-free shampoos suited to your hair type.

If you choose to use rosemary oil or similar products, always perform a patch test, use as directed, and discontinue use if any irritation occurs. Combining safe cosmetic practices with evidence-based medical advice offers the most balanced approach to managing hair health.

Sources: NHS: Hair loss treatments; NICE CKS: Male pattern hair loss; Female pattern hair loss; BNF: Minoxidil (topical); Finasteride; MHRA/eMC SmPC: Regaine for Men Extra Strength 5% Foam; Regaine for Women Once a Day 5% Foam; Finasteride 1 mg tablets; Loniten (minoxidil tablets); MHRA Drug Safety Update: Finasteride — risk of psychiatric and sexual side effects (2024); BAD patient information leaflets.

Frequently Asked Questions